177 related articles for article (PubMed ID: 16123308)
21. Evaluation of 50-kHz ultrasonic vocalizations in animal models of mania: Ketamine and lisdexamfetamine-induced hyperlocomotion in rats.
Wendler E; de Souza CP; Vecchia DD; Kanazawa LKS; de Almeida Soares Hocayen P; Wöhr M; Schwarting RKW; Andreatini R
Eur Neuropsychopharmacol; 2016 Dec; 26(12):1900-1908. PubMed ID: 27842942
[TBL] [Abstract][Full Text] [Related]
22. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
Kalinichev M; Dawson LA
Int J Neuropsychopharmacol; 2011 Sep; 14(8):1051-67. PubMed ID: 21208504
[TBL] [Abstract][Full Text] [Related]
23. Lithium normalizes amphetamine-induced changes in striatal FoxO1 phosphorylation and behaviors in rats.
Zheng W; Zeng Z; Bhardwaj SK; Jamali S; Srivastava LK
Neuroreport; 2013 Jul; 24(10):560-5. PubMed ID: 23652158
[TBL] [Abstract][Full Text] [Related]
24. Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice.
Caldwell HK; Stephens SL; Young WS
Mol Psychiatry; 2009 Feb; 14(2):190-6. PubMed ID: 18227836
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of behavioral and neurochemical changes induced by ketamine in rats: implications as an animal model of mania.
Ghedim FV; Fraga Dde B; Deroza PF; Oliveira MB; Valvassori SS; Steckert AV; Budni J; Dal-Pizzol F; Quevedo J; Zugno AI
J Psychiatr Res; 2012 Dec; 46(12):1569-75. PubMed ID: 22998743
[TBL] [Abstract][Full Text] [Related]
26. Anticonvulsant medications attenuate amphetamine-induced deficits in behavioral inhibition but not decision making under risk on a rat gambling task.
Tremblay M; Winstanley CA
Behav Brain Res; 2016 Nov; 314():143-51. PubMed ID: 27515288
[TBL] [Abstract][Full Text] [Related]
27. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
Moy SS; Perez A; Koller BH; Duncan GE
Brain Res; 2006 May; 1089(1):186-94. PubMed ID: 16638606
[TBL] [Abstract][Full Text] [Related]
28. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.
Braff DL; Geyer MA; Swerdlow NR
Psychopharmacology (Berl); 2001 Jul; 156(2-3):234-58. PubMed ID: 11549226
[TBL] [Abstract][Full Text] [Related]
29. Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window.
Sills TL
Brain Res Bull; 1999 Mar; 48(4):445-8. PubMed ID: 10357078
[TBL] [Abstract][Full Text] [Related]
30. Questioning the predictive validity of the amphetamine-induced hyperactivity model for screening mood stabilizing drugs.
Lan A; Einat H
Behav Brain Res; 2019 Apr; 362():109-113. PubMed ID: 30630015
[TBL] [Abstract][Full Text] [Related]
31. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
[TBL] [Abstract][Full Text] [Related]
32. Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.
Basta-Kaim A; Budziszewska B; Jaworska-Feil L; Tetich M; Kubera M; Leśkiewicz M; Lasoń W
Eur J Pharmacol; 2004 Jul; 495(2-3):103-10. PubMed ID: 15249158
[TBL] [Abstract][Full Text] [Related]
33. Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex.
Tan H; Young LT; Shao L; Che Y; Honer WG; Wang JF
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1275-85. PubMed ID: 21939588
[TBL] [Abstract][Full Text] [Related]
34. Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine.
Pedrazzi JF; Issy AC; Gomes FV; Guimarães FS; Del-Bel EA
Psychopharmacology (Berl); 2015 Aug; 232(16):3057-65. PubMed ID: 25943166
[TBL] [Abstract][Full Text] [Related]
35. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium.
Gould TD; O'Donnell KC; Picchini AM; Manji HK
Neuropsychopharmacology; 2007 Jun; 32(6):1321-33. PubMed ID: 17151598
[TBL] [Abstract][Full Text] [Related]
36. Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study.
Musetti L; Tundo A; Benedetti A; Massimetti G; Cambiali E; Pergentini I; Del Grande C; Dell'Osso L
Hum Psychopharmacol; 2018 Nov; 33(6):e2676. PubMed ID: 30311959
[TBL] [Abstract][Full Text] [Related]
37. Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder.
Dencker D; Husum H
Behav Brain Res; 2010 Feb; 207(1):78-83. PubMed ID: 19815032
[TBL] [Abstract][Full Text] [Related]
38. The antimanic-like effect of phenytoin and carbamazepine on methylphenidate-induced hyperlocomotion: role of voltage-gated sodium channels.
Tonelli DA; Pereira M; Siba IP; Martynhak BJ; Correia D; Casarotto PC; Biojone C; Guimarães FS; Joca SL; Andreatini R
Fundam Clin Pharmacol; 2013 Dec; 27(6):650-5. PubMed ID: 23437921
[TBL] [Abstract][Full Text] [Related]
39. Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms.
de Queiroz AIG; Chaves Filho AJM; Araújo TDS; Lima CNC; Machado MJS; Carvalho AF; Vasconcelos SMM; de Lucena DF; Quevedo J; Macedo D
J Affect Disord; 2018 Jan; 225():40-51. PubMed ID: 28783519
[TBL] [Abstract][Full Text] [Related]
40. Effects of mood stabilizers on DNA damage in an animal model of mania.
Andreazza AC; Kauer-Sant'Anna M; Frey BN; Stertz L; Zanotto C; Ribeiro L; Giasson K; Valvassori SS; Réus GZ; Salvador M; Quevedo J; Gonçalves CA; Kapczinski F
J Psychiatry Neurosci; 2008 Nov; 33(6):516-24. PubMed ID: 18982174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
